tiprankstipranks
Trending News
More News >
MeVis Medical Solutions AG (GB:0HI7)
LSE:0HI7
UK Market
Advertisement

MeVis Medical Solutions (0HI7) Ratios

Compare
0 Followers

MeVis Medical Solutions Ratios

GB:0HI7's free cash flow for Q2 2024 was €0.39. For the 2024 fiscal year, GB:0HI7's free cash flow was decreased by € and operating cash flow was €0.26. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.50 1.66 1.50 1.63 1.48
Quick Ratio
1.50 1.66 1.49 1.62 1.47
Cash Ratio
1.03 1.13 0.96 1.15 0.53
Solvency Ratio
0.54 0.49 0.59 0.48 0.59
Operating Cash Flow Ratio
0.49 0.85 0.50 1.37 0.39
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
€ 890.18K€ 1.14M€ 1.13M€ 1.17M€ 1.09M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.49 1.57 1.75 1.54 1.56
Debt Service Coverage Ratio
239.22 118.12 2.05K 488.87 501.64
Interest Coverage Ratio
204.00 150.47 2.05K 485.12 495.07
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.01 0.02 <0.01 <0.01 <0.01
Net Debt to EBITDA
-1.35 -1.50 -1.17 -1.42 -0.66
Profitability Margins
Gross Profit Margin
97.11%40.38%96.02%97.31%96.34%
EBIT Margin
27.73%29.27%42.00%28.63%33.89%
EBITDA Margin
28.40%29.83%42.48%33.15%34.87%
Operating Profit Margin
23.58%37.16%42.00%32.38%33.89%
Pretax Profit Margin
27.62%29.03%41.98%28.56%33.82%
Net Profit Margin
26.87%28.37%41.52%28.04%33.30%
Continuous Operations Profit Margin
26.87%28.37%41.52%28.04%33.30%
Net Income Per EBT
97.30%97.73%98.89%98.16%98.44%
EBT Per EBIT
117.12%78.12%99.95%88.21%99.80%
Return on Assets (ROA)
17.22%17.54%24.96%16.51%20.52%
Return on Equity (ROE)
25.59%27.60%43.69%25.50%32.00%
Return on Capital Employed (ROCE)
19.89%30.39%36.60%25.14%28.58%
Return on Invested Capital (ROIC)
19.44%29.70%36.20%24.68%28.13%
Return on Tangible Assets
17.22%17.54%24.96%16.51%20.53%
Earnings Yield
10.10%9.52%12.51%7.66%9.86%
Efficiency Ratios
Receivables Turnover
6.14 6.54 4.68 7.14 6.24
Payables Turnover
5.73 134.73 3.88 1.82 6.75
Inventory Turnover
0.00 0.00 5.59 4.36 12.96
Fixed Asset Turnover
53.84 118.73 115.80 133.13 88.14
Asset Turnover
0.64 0.62 0.60 0.59 0.62
Working Capital Turnover Ratio
4.40 3.71 4.15 4.16 4.80
Cash Conversion Cycle
-4.27 53.11 49.06 -65.46 32.64
Days of Sales Outstanding
59.46 55.81 77.96 51.14 58.53
Days of Inventory Outstanding
0.00 0.00 65.24 83.72 28.17
Days of Payables Outstanding
63.74 2.71 94.15 200.32 54.06
Operating Cycle
59.46 55.81 143.20 134.87 86.70
Cash Flow Ratios
Operating Cash Flow Per Share
1.73 3.22 2.67 5.02 1.59
Free Cash Flow Per Share
1.56 3.17 2.60 4.99 1.53
CapEx Per Share
0.17 0.04 0.07 0.03 0.06
Free Cash Flow to Operating Cash Flow
0.90 0.99 0.97 0.99 0.96
Dividend Paid and CapEx Coverage Ratio
0.60 0.74 1.04 1.59 1.73
Capital Expenditure Coverage Ratio
10.42 73.44 36.49 179.53 28.18
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
0.19 0.34 0.26 0.56 0.17
Free Cash Flow Yield
6.30%11.17%7.59%15.30%4.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
9.90 10.51 7.99 13.05 10.15
Price-to-Sales (P/S) Ratio
2.66 2.98 3.32 3.66 3.38
Price-to-Book (P/B) Ratio
2.53 2.90 3.49 3.33 3.25
Price-to-Free Cash Flow (P/FCF) Ratio
15.87 8.95 13.18 6.53 20.76
Price-to-Operating Cash Flow Ratio
14.35 8.83 12.81 6.50 20.03
Price-to-Earnings Growth (PEG) Ratio
1.26 -0.28 0.11 -0.65 -0.35
Price-to-Fair Value
2.53 2.90 3.49 3.33 3.25
Enterprise Value Multiple
8.01 8.50 6.64 9.62 9.03
Enterprise Value
38.61M 43.94M 52.92M 51.71M 53.92M
EV to EBITDA
8.01 8.50 6.64 9.62 9.03
EV to Sales
2.27 2.53 2.82 3.19 3.15
EV to Free Cash Flow
13.57 7.61 11.20 5.69 19.35
EV to Operating Cash Flow
12.27 7.51 10.90 5.66 18.66
Tangible Book Value Per Share
9.79 9.79 9.79 9.79 9.79
Shareholders’ Equity Per Share
9.79 9.79 9.79 9.79 9.79
Tax and Other Ratios
Effective Tax Rate
0.03 0.02 0.01 0.02 0.02
Revenue Per Share
9.33 9.53 10.31 8.91 9.41
Net Income Per Share
2.51 2.70 4.28 2.50 3.13
Tax Burden
0.97 0.98 0.99 0.98 0.98
Interest Burden
1.00 0.99 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.03 0.03 0.02 0.05 0.04
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.69 1.19 0.62 2.01 0.51
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis